CClinicalTrials.gg
Not yet recruitingNCT06858891Updated Mar 6, 2025

The Effect of TAP Block on Maternal-Infant Bonding

An interventional study of Transversus abdominis plane (TAP) block in Cesarean Section and Transversus Abdominis Plane (TAP) Block, sponsored by Adiyaman University Research Hospital. Not yet recruiting. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-03-06.

Sponsored by Adiyaman University Research Hospital · Not applicable, Interventional, and Screening

From the registry’s dates

  • Primary completion was expected by Apr 2025, 1 year 6 months ago, but the record still lists the study as not yet recruiting.
Phase
Not applicable
Study type
Interventional
Enrollment
132
Allocation
Randomized
Ages
18 Years and older
Sex
Female
01

Study summary

Cesarean delivery is a common surgical procedure that is typically performed under spinal anesthesia. Postoperative pain management has a significant impact on both the mother's physical recovery and the quality of maternal-infant bonding. The quality of maternal-infant bonding is influenced by various factors, including postoperative pain, early mobilization, initiation of breastfeeding, stress, psychological status, and hormonal balance. Studies have reported that adequate postoperative pain management, early breastfeeding, and early mobilization have positive effects on maternal-infant bonding.

Transversus abdominis plane (TAP) block is a regional anesthesia technique known for its efficacy in controlling postoperative pain. Bilateral TAP block performed after cesarean section has been associated with lower pain scores, reduced analgesic consumption, and shorter hospital stays. However, its impact on maternal-infant bonding has not been fully elucidated.

This study aims to investigate the effect of bilateral TAP block on maternal-infant bonding in women undergoing cesarean section under spinal anesthesia.

Read the detailed description

This study aims to investigate the effect of TAP block on maternal-infant bonding in women undergoing cesarean section under spinal anesthesia. Participants will be randomly assigned to two groups: one group will receive a TAP block in addition to standard care, while the other group will receive only standard pain management. Maternal-infant bonding will be assessed using the maternal bonding scale and behavioral evaluations at 48 hours and one month postpartum.

The primary outcome is to evaluate whether the TAP block improves early bonding by reducing pain and enhancing maternal comfort. Secondary outcomes include maternal pain scores, mobilization time, and initiation of breastfeeding. This study aims to contribute to the optimization of pain management strategies in cesarean deliveries, ultimately improving both maternal recovery and neonatal outcomes.

02

Conditions studied

  • Cesarean Section
  • Transversus Abdominis Plane (TAP) Block

Keywords

  • cesarean section
  • Transversus Abdominis Plane (TAP) Block
  • Maternal-Infant Bonding
03

In context

Lead sponsor

Adiyaman University Research Hospital is the lead sponsor of 48 studies on the registry; 9 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No

Inclusion criteria

  • 18 aged or older patients,
  • Agree to participate in the study
  • Pregnant women without any maternal or fetal pathology during the pregnancy.

Exclusion criteria

Exclusion Criteria:

  • \<18 age
  • Deny to participate in the study
  • maternal or fetal pathology during the pregnancy
  • Allergy to local anesthetics
  • local ingection at block side
05

Study design

Phase
Not applicable
Primary purpose
Screening
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Investigator)
Enrollment
132 participants (estimated)

Study arms

  • No intervention
    Control group

    standard pain management

  • Experimental
    Block group

    standard pain management + Bilateral TAP block

    Procedure: Transversus abdominis plane (TAP) block

Interventions

  • ProcedureTransversus abdominis plane (TAP) block

    Under ultrasound guidance, 20 cc of 0.25% bupivacaine was planned to be administered between the internal oblique and transversus abdominis fascial planes on both lateral aspects of the anterior abdominal wall.

06

What researchers measure

Primary outcomes

  1. Perceived Maternal Parenting Self-Efficacy (PMP S-E) score

    The PMP S-E is a questionnaire consisting of 18 questions that assess the mother's bond with her baby and her sense of parenthood. Each question consists of 4 options and will be scored on a scale from 0 to 3. The total score of the questionnaire will range from 0 to 54.

    Time frame: Postoperative 48th hour, based on a single assessment

Secondary outcomes

  1. Visual Analog scale (VAS) score

    Postoperative pain scores will be assesed with visual analog scale at postoperative period. Vas score will range to 0-10. O refers to no pain and 10 refers to the worst pain ever had.

    Time frame: Postoperative 2th, 4th, 6th, 12th and 24th hours

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 6, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06858891
Lead sponsor
Adiyaman University Research Hospital
Responsible party
Nezir Yılmaz (Associate Professor, Adiyaman University Research Hospital) — Principal investigator
First posted
Mar 5, 2025
Start date
Mar 10, 2025 (estimated)
Primary completion
Apr 5, 2025 (estimated)
Completion
Apr 10, 2025 (estimated)
Last update
Mar 6, 2025

Study contacts

Nezir Yılmaz, Associate Professor
Contact
yilmaznezir@hotmail.com
+905068939496

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Feb 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion